Skip to content
ClinCalc Pro
Menu
Strong Opioid Analgesic — Step 3 WHO Ladder

Oxycodone

Brand names: OxyNorm (immediate-release), OxyContin (modified-release)

Oxycodone is a strong opioid analgesic, available in immediate-release and modified-release oral preparations and as an injection, used for moderate-to-severe pain including post-operative, cancer and palliative care pain.

Dosing — being independently re-sourced

ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.

Clinical monograph

How it works

It is a mu-opioid receptor agonist (with some kappa activity) that reduces pain transmission and perception within the central nervous system.

Prescribing in practice

  • Respiratory depression is the principal hazard and is increased by concomitant benzodiazepines, gabapentinoids and other CNS depressants, so combine with caution.
  • Reduce doses in hepatic and renal impairment and in the elderly, and do not interchange immediate-release and modified-release preparations.
  • It carries a risk of tolerance, dependence and misuse, so review regularly and taper rather than stop abruptly after prolonged use.

Monitoring

Monitor analgesic response, sedation, respiratory rate and bowel function, with closer review when titrating the dose or combining with other sedatives.

Counselling the patient

  • This medicine can make you drowsy, so do not drive until you know how it affects you.
  • Take a regular laxative to prevent constipation.
  • Avoid alcohol and take only the dose prescribed.

Evidence & guidelines

Oxycodone is an established alternative strong opioid where morphine is unsuitable, consistent with NICE pain and palliative care guidance.

Reference: NICE NG31; Palliative Care Formulary (PCF6); Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).

Related

Curated clinical cross-links plus same-class fallbacks.